These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Allogeneic bone marrow transplantation for hemophagocytic lymphohistiocytosis in Sweden. Bolme P, Henter JI, Winiarski J, Elinder G, Ljungman P, Lönnerholm G, Ringdén O. Bone Marrow Transplant; 1995 Mar; 15(3):331-5. PubMed ID: 7599555 [Abstract] [Full Text] [Related]
4. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors. Soiffer RJ, Mauch P, Fairclough D, Alyea E, Anderson K, Fisher D, Freedman A, Bartlett-Pandite L, Robertson M, Schlossman R, Gollob J, Marcus K, Murray C, Kuhlman C, Freeman A, Nadler L, Ritz J. Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736 [Abstract] [Full Text] [Related]
5. A single centre experience with allogeneic stem cell transplantation for severe aplastic anaemia in childhood. Ladenstein R, Peters C, Minkov M, Emminger-Schmidmeier W, Mann G, Höcker P, Hawliczek R, Rosenmayr A, Fink FM, Niederwieser D, Gadner H. Klin Padiatr; 1997 Apr; 209(4):201-8. PubMed ID: 9293451 [Abstract] [Full Text] [Related]
6. Allogeneic peripheral blood stem cell transplantation in patients with early-phase hematologic malignancy: a retrospective comparison of short-term outcome with bone marrow transplantation. Lemoli RM, Bandini G, Leopardi G, Rosti G, Bonini A, Fortuna A, Rondelli D, Mangianti S, Motta MR, Rizzi S, Tassi C, Cavo M, Remiddi C, Curti A, Conte R, Tura S. Haematologica; 1998 Jan; 83(1):48-55. PubMed ID: 9542323 [Abstract] [Full Text] [Related]
7. CD8+ T-cell-depleted, matched unrelated donor, allogeneic bone marrow transplantation for advanced AML using busulfan-based preparative regimens. Kalaycio M, Rybicki L, Pohlman B, Sobecks R, Ball E, Cook D, Andresen S, Kuczkowski E, Bolwell B. Bone Marrow Transplant; 2005 Feb; 35(3):247-52. PubMed ID: 15580282 [Abstract] [Full Text] [Related]
9. Allogeneic peripheral blood progenitor cells for treatment of relapse after bone marrow transplantation. Glass B, Majolino I, Dreger P, Scimè R, Santoro A, Vasta S, Suttorp M, Haferlach T, Schmitz N. Bone Marrow Transplant; 1997 Oct; 20(7):533-41. PubMed ID: 9337054 [Abstract] [Full Text] [Related]
10. Allogeneic stem cell transplantation after a fludarabine/busulfan-based reduced-intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemia. Kröger N, Bornhäuser M, Ehninger G, Schwerdtfeger R, Biersack H, Sayer HG, Wandt H, Schäfer-Eckardt K, Beyer J, Kiehl M, Zander AR, German Cooperative Transplant Study Group. Ann Hematol; 2003 Jun; 82(6):336-42. PubMed ID: 12728337 [Abstract] [Full Text] [Related]
11. Unrelated donor bone marrow transplantation without T cell depletion using a chemotherapy only condition regimen. Low incidence of failed engraftment and severe acute GVHD. Topolsky D, Crilley P, Styler MJ, Bulova S, Brodsky I, Marks DI. Bone Marrow Transplant; 1996 Apr; 17(4):549-54. PubMed ID: 8722353 [Abstract] [Full Text] [Related]
13. Bone marrow transplantation from genetically HLA-nonidentical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: use of two monoclonal antibodies to prevent graft rejection. Jabado N, Le Deist F, Cant A, De Graeff-Meeders ER, Fasth A, Morgan G, Vellodi A, Hale G, Bujan W, Thomas C, Cavazzana-Calvo M, Wijdenes J, Fischer A. Pediatrics; 1996 Sep; 98(3 Pt 1):420-8. PubMed ID: 8784367 [Abstract] [Full Text] [Related]
14. Unrelated bone marrow transplantation for high-risk anaplastic large cell lymphoma in pediatric patients: a single center case series. Cesaro S, Pillon M, Visintin G, Putti MC, Gazzola MV, D'Amore E, Scarzello G, Zanesco L, Messina C, Rosolen A. Eur J Haematol; 2005 Jul; 75(1):22-6. PubMed ID: 15946306 [Abstract] [Full Text] [Related]
15. Successful engraftment and stable full donor chimerism after myeloablation with thiotepa, fludarabine, and melphalan and CD34-selected peripheral allogeneic stem cell transplantation in hemophagocytic lymphohistiocytosis. Cesaro S, Gazzola MV, Marson P, Calore E, Caenazzo L, Destro R, De Silvestro G, Varotto S, Pillon M, Zanesco L, Messina C. Am J Hematol; 2003 Feb; 72(2):143-6. PubMed ID: 12555220 [Abstract] [Full Text] [Related]
16. Unrelated allogeneic bone marrow transplantation using high-dose busulfan and cyclophosphamide (BU-CY) for the preparative regimen. Sahebi F, Copelan E, Crilley P, Bolwell B, Avalos B, Klein J, Territo M, Gajewski J. Bone Marrow Transplant; 1996 May; 17(5):685-9. PubMed ID: 8733682 [Abstract] [Full Text] [Related]
17. Allogeneic hematopoietic stem cell transplantation for patients with hemophagocytic syndrome (HPS) in Japan. Imashuku S, Hibi S, Todo S, Sako M, Inoue M, Kawa K, Koike K, Iwai A, Tsuchiya S, Akiyama Y, Kotani T, Kawamura Y, Hirosawa M, Hasegawa D, Kosaka Y, Yamaguchi H, Ishii E, Kato K, Ishii M, Kigasawa H. Bone Marrow Transplant; 1999 Mar; 23(6):569-72. PubMed ID: 10217187 [Abstract] [Full Text] [Related]
19. An unusual cause of multiple organ dysfunction syndrome in the pediatric intensive care unit: hemophagocytic lymphohistiocytosis. Karapinar B, Yilmaz D, Balkan C, Akin M, Ay Y, Kvakli K. Pediatr Crit Care Med; 2009 May; 10(3):285-90. PubMed ID: 19433941 [Abstract] [Full Text] [Related]